The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
<h4>Introduction</h4>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies such as anti-Sm. Studies in patients with SLE and murine models of lupus reveal that the most critical anti-Sm autoantibodies are predominantly direct agains...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f69cb4eb2bf4954bb583b30ad84d7bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5f69cb4eb2bf4954bb583b30ad84d7bc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5f69cb4eb2bf4954bb583b30ad84d7bc2021-12-02T20:13:27ZThe DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.1932-620310.1371/journal.pone.0259114https://doaj.org/article/5f69cb4eb2bf4954bb583b30ad84d7bc2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259114https://doaj.org/toc/1932-6203<h4>Introduction</h4>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies such as anti-Sm. Studies in patients with SLE and murine models of lupus reveal that the most critical anti-Sm autoantibodies are predominantly direct against D1(83-119), D2, and B´/B epitopes.<h4>Objectives</h4>The present study aimed to analyze the induction of antigen-specific tolerance after prophylactic immunization with a DNA vaccine encoding the epitopes: D183-119, D2, B´/B, and B´/BCOOH in co-vaccination with IFN-γ or IL-10 in a murine model of lupus induced by pristane.<h4>Material and methods</h4>To obtain endotoxin-free DNA vaccines, direct cloning techniques using pcDNA were performed: D183-119, D2, B´/B, B´/BCOOH, IFN-γ, or IL-10. Lupus was induced by 0.5 mL of pristane via intraperitoneal in BALB/c female mice. Immunoprecipitation with K562 cells was metabolically labeled with 35S and ELISA to detect serum antibodies or mice IgG1, IgG2a isotypes. ELISA determined IL-10 and IFN-γ from splenocytes supernatants. Proteinuria was assessed monthly, and lupus nephritis was evaluated by immunofluorescence, and electron microscopy.<h4>Results</h4>The prophylactic co-vaccination with D2/IL-10 reduced the expression of kidney damage observed by electron microscopy, direct immunofluorescence, and H & E, along with reduced level of anti-nRNP/Sm antibodies (P = 0.048).<h4>Conclusion</h4>The prophylactic co-vaccination of IL-10 with D2 in pristane-induced lupus ameliorates the renal damage maybe by acting as prophylactic DNA tolerizing therapy.Beatriz Teresita Martín-MárquezMinoru SatohRogelio Hernández-PandoErika Aurora Martínez-GarcíaMarcelo Heron PetriFlavio Sandoval-GarcíaOscar Pizano-MartinezTrinidad García-IglesiasFernanda Isadora Corona-MerazMonica Vázquez-Del MercadoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0259114 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Beatriz Teresita Martín-Márquez Minoru Satoh Rogelio Hernández-Pando Erika Aurora Martínez-García Marcelo Heron Petri Flavio Sandoval-García Oscar Pizano-Martinez Trinidad García-Iglesias Fernanda Isadora Corona-Meraz Monica Vázquez-Del Mercado The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
description |
<h4>Introduction</h4>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies such as anti-Sm. Studies in patients with SLE and murine models of lupus reveal that the most critical anti-Sm autoantibodies are predominantly direct against D1(83-119), D2, and B´/B epitopes.<h4>Objectives</h4>The present study aimed to analyze the induction of antigen-specific tolerance after prophylactic immunization with a DNA vaccine encoding the epitopes: D183-119, D2, B´/B, and B´/BCOOH in co-vaccination with IFN-γ or IL-10 in a murine model of lupus induced by pristane.<h4>Material and methods</h4>To obtain endotoxin-free DNA vaccines, direct cloning techniques using pcDNA were performed: D183-119, D2, B´/B, B´/BCOOH, IFN-γ, or IL-10. Lupus was induced by 0.5 mL of pristane via intraperitoneal in BALB/c female mice. Immunoprecipitation with K562 cells was metabolically labeled with 35S and ELISA to detect serum antibodies or mice IgG1, IgG2a isotypes. ELISA determined IL-10 and IFN-γ from splenocytes supernatants. Proteinuria was assessed monthly, and lupus nephritis was evaluated by immunofluorescence, and electron microscopy.<h4>Results</h4>The prophylactic co-vaccination with D2/IL-10 reduced the expression of kidney damage observed by electron microscopy, direct immunofluorescence, and H & E, along with reduced level of anti-nRNP/Sm antibodies (P = 0.048).<h4>Conclusion</h4>The prophylactic co-vaccination of IL-10 with D2 in pristane-induced lupus ameliorates the renal damage maybe by acting as prophylactic DNA tolerizing therapy. |
format |
article |
author |
Beatriz Teresita Martín-Márquez Minoru Satoh Rogelio Hernández-Pando Erika Aurora Martínez-García Marcelo Heron Petri Flavio Sandoval-García Oscar Pizano-Martinez Trinidad García-Iglesias Fernanda Isadora Corona-Meraz Monica Vázquez-Del Mercado |
author_facet |
Beatriz Teresita Martín-Márquez Minoru Satoh Rogelio Hernández-Pando Erika Aurora Martínez-García Marcelo Heron Petri Flavio Sandoval-García Oscar Pizano-Martinez Trinidad García-Iglesias Fernanda Isadora Corona-Meraz Monica Vázquez-Del Mercado |
author_sort |
Beatriz Teresita Martín-Márquez |
title |
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
title_short |
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
title_full |
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
title_fullStr |
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
title_full_unstemmed |
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
title_sort |
dna co-vaccination using sm antigen and il-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/5f69cb4eb2bf4954bb583b30ad84d7bc |
work_keys_str_mv |
AT beatrizteresitamartinmarquez thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT minorusatoh thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT rogeliohernandezpando thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT erikaauroramartinezgarcia thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT marceloheronpetri thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT flaviosandovalgarcia thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT oscarpizanomartinez thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT trinidadgarciaiglesias thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT fernandaisadoracoronameraz thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT monicavazquezdelmercado thednacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT beatrizteresitamartinmarquez dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT minorusatoh dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT rogeliohernandezpando dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT erikaauroramartinezgarcia dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT marceloheronpetri dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT flaviosandovalgarcia dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT oscarpizanomartinez dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT trinidadgarciaiglesias dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT fernandaisadoracoronameraz dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane AT monicavazquezdelmercado dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane |
_version_ |
1718374768140353536 |